Hongbo Chi

Active 1995–2025

118
Papers
29,363
Citations
81
h-index
113
i10-index

Citations

Citations per year for Hongbo Chi1991: 2 citations1995: 25 citations1996: 100 citations1997: 146 citations1998: 114 citations1999: 115 citations2000: 126 citations2001: 84 citations2002: 94 citations2003: 72 citations2004: 94 citations2005: 79 citations2006: 114 citations2007: 83 citations2008: 106 citations2009: 94 citations2010: 124 citations2011: 133 citations2012: 227 citations2013: 233 citations2014: 288 citations2015: 309 citations2016: 374 citations2017: 431 citations2018: 434 citations2019: 1,039 citations2020: 1,309 citations2021: 1,416 citations2022: 1,320 citations2023: 1,069 citations2024: 1,816 citations2025: 1,233 citations2026: 45 citations1992–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,107 citing papers, 29.9% of this breakdownChina: 2,641 citing papers, 19.2% of this breakdownUnited Kingdom: 747 citing papers, 5.4% of this breakdownGermany: 736 citing papers, 5.4% of this breakdownJapan: 449 citing papers, 3.3% of this breakdownCanada: 447 citing papers, 3.3% of this breakdownItaly: 399 citing papers, 2.9% of this breakdownFrance: 373 citing papers, 2.7% of this breakdownAustralia: 321 citing papers, 2.3% of this breakdownSwitzerland: 273 citing papers, 2% of this breakdownSpain: 250 citing papers, 1.8% of this breakdownSouth Korea: 236 citing papers, 1.7% of this breakdown
0%29.9%Other 20.1%

Fields

  • Medicine36.3%
  • Biochemistry, Genetics and Molecular Biology32.3%
  • Immunology and Microbiology24%
  • Neuroscience4.2%
  • Nursing0.7%
  • Agricultural and Biological Sciences0.6%
  • Other1.9%

Topics

  • Immune Cell Function and Interaction7.9%
  • Alzheimer's disease research and treatments5.2%
  • T-cell and B-cell Immunology5%
  • Immune cells in cancer3.4%
  • Cancer, Hypoxia, and Metabolism2.6%
  • Immunotherapy and Immune Responses2.5%
  • Other73.4%

Coauthors

All papers

Open in search
  1. The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation

    Authors: , , , , , , , , , , - Immunity 2011 cited by 2,111

  2. Metabolic coordination of T cell quiescence and activation

    Authors: , , - Nature reviews. Immunology 2019 cited by 754

  3. SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity

    Authors: , , , , , , , , , , , , , , - Nature 2023 cited by 261

  4. HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells

    Authors: , , , , , , - The Journal of Experimental Medicine 2011 cited by 1,763

  5. Lipid signalling enforces functional specialization of Treg cells in tumours

    Authors: , , , , , , , , , , , - Nature 2021 cited by 412

  6. Lipid metabolism in T cell signaling and function

    Authors: , , , - Nature Chemical Biology 2022 cited by 262

  7. Regulation and function of mTOR signalling in T cell fate decisions

    Authors: - Nature reviews. Immunology 2012 cited by 1,006

  8. Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bin Zhang, Thomas G. Beach, Gang Yu, Junmin Peng - Neuron 2020 cited by 608

  9. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy

    Authors: , , , , , , , , , , , , , , , , - Nature 2019 cited by 436

  10. Helper T cell differentiation

    Authors: , , - Cellular and Molecular Immunology 2019 cited by 490

  11. Metabolic adaptation of lymphocytes in immunity and disease

    Authors: , - Immunity 2022 cited by 294

  12. Principles and therapeutic applications of adaptive immunity

    Authors: , , - Cell 2024 cited by 308

  13. Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer

    Authors: , , , , , , , , , , , - Nature 2023 cited by 159

  14. mTORC1 couples immune signals and metabolic programming to establish Treg-cell function

    Authors: , , , , , - Nature 2013 cited by 796

  15. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , P. E. Fraser, Johanna M. Rommens, Peter St George‐Hyslop - Nature 1995 cited by 4,061

  16. Integrative Proteomics and Phosphoproteomics Profiling Reveals Dynamic Signaling Networks and Bioenergetics Pathways Underlying T Cell Activation

    Authors: , , , , , , , , , , , , - Immunity 2017 cited by 387

  17. CXCR6 orchestrates brain CD8+ T cell residency and limits mouse Alzheimer’s disease pathology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2023 cited by 186

  18. Metabolic programs of T cell tissue residency empower tumour immunity

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2023 cited by 123

  19. cBAF complex components and MYC cooperate early in CD8+ T cell fate

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 161

  20. Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hardik Shah, Brandon Faubert, Shannon Elf, Brian T. Layden, B M Bissonnette, Yu‐Ying He, Justin Kline, Hui Mao, Kunle Odunsi, Xue Gao, Hongbo Chi, Chuan He, Jing Chen - Nature 2023 cited by 130

  21. In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8+ T cell fate decisions

    Authors: , , , , , , , , , , , , , , , - Cell 2021 cited by 153

  22. CRISPR screens unveil signal hubs for nutrient licensing of T cell immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2021 cited by 111

  23. Immunometabolism at the intersection of metabolic signaling, cell fate, and systems immunology

    Authors: - Cellular and Molecular Immunology 2022 cited by 140

  24. Signaling networks in immunometabolism

    Authors: , , , , - Cell Research 2020 cited by 241